Experience of using nitric oxide in a patient with acute myocardial infarction complicated by cardiogenic shock and pulmonary edema (clinical case)-Reference-Cited by-同舟云学术

Experience of using nitric oxide in a patient with acute myocardial infarction complicated by cardiogenic shock and pulmonary edema (clinical case)

Published:2024-06-14 Issue:3 Volume:21 Page:109-116
ISSN:2541-8653
Container-title:Messenger of ANESTHESIOLOGY AND RESUSCITATION
language:
Short-container-title:Vestn. anesteziol. reanimatol.

Author:

Shen N. P.¹^ORCID,Vitik A A¹^ORCID,Artemchuk A. V.²^ORCID,Momich M. M.²^ORCID,Gryaznova E. A.³^ORCID

Affiliation:

1. Tyumen State Medical University ; Regional Clinical Hospital № 1

2. Regional Clinical Hospital № 1

3. Tyumen State Medical University

Abstract

A clinical case demonstrates the possibility of using inhaled nitric oxide therapy in myocardial infarction. This method was connected to ongoing intensive therapy due to the lack of positive dynamics, persistent symptoms of cardiogenic shock, pulmonary edema and arterial hypoxemia. The result was a positive effect.

Publisher

FSBEI HE I.P. Pavlov SPbSMU MOH Russia

Reference29 articles.

1. Bautin A.E., Yakovlev A.S., Zayashnikov S.V. et al. Comparison of hemodynamic effects of inhaled iloprost and nitric oxide when administered to patients with severe left ventricular systolic dysfunction. Russian Journal of Cardiology, 2017, vol. 12, no. 152, pp. 97–103. (In Russ.) DOI: 10.15829/1560-4071-2017-12-97-103.

2. Bautin A.E., Ksendikova A.V., Yakovlev A.S. et al. Anesthesiological support and intensive care in the perioperative period in patients with pulmonary hypertension caused by left heart disease. Bulletin of Anesthesiology and Resuscitation, 2019, vol. 16, no. 3, pp. 33–40. (In Russ.) DOI: 10.21292/2078-5658-2019-16-3-33-40.

3. Bautin A.E., Selemir V.D., Nurgalieva A.I. et al. Inhalation therapy with nitric oxide synthesized from atmospheric air in the postoperative period of cardiac surgery in children: a single-center retrospective cohort study. A. I. Saltanov Intensive Care Bulletin, 2021, no. 3, pp. 98–107. (In Russ.) DOI: 10.21320/1818-474X-2021-3-98-107.

4. Bautin A.E., Selemir V.D., Shafikova A.I. et al. Evaluation of clinical efficacy and safety of nitric oxide therapy synthesized from atmospheric air in the postoperative period of cardiac surgery. Translational Medicine, 2021, vol. 8, no. 1, pp. 38–50. (In Russ.) DOI: 10.18705/2311-4495-2021-8-1-38-50.

5. Adusumilli N.C., Zhang D., Friedman J.M., Friedman A.J. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide, 2020, vol. 103, pp. 4–8. DOI: 10.1016/j.niox.2020.07.003.